amibegron (SR58611A)

DRUG4 trials

Sponsors

Sanofi

Conditions

Major Depressive DisorderMajor Depressive Disorders

Phase 3

Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS)

CompletedNCT00385307

SanofiMajor Depressive Disorder

Start: 2006-09-30End: 2007-11-30Updated: 2009-03-25

Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine

CompletedNCT00825058

SanofiMajor Depressive Disorders

Start: 2003-11-30End: 2004-10-31Updated: 2009-03-25

Efficacy and Safety of One Single Dose of SR58611 Compared to Placebo and Paroxetine

CompletedNCT00825019

SanofiMajor Depressive Disorders

Start: 2003-09-30End: 2004-12-31Updated: 2009-03-25

Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder

CompletedNCT00855530

SanofiMajor Depressive Disorders

Start: 2005-09-30End: 2007-07-31Updated: 2009-03-25